[HTML][HTML] Antibiotic discovery: where have we come from, where do we go?
B Ribeiro da Cunha, LP Fonseca, CRC Calado - Antibiotics, 2019 - mdpi.com
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
Antibiotic discovery: where have we come from, where do we go?
B Ribeiro Da Cunha, LP Fonseca, C Calado - Antibiotics, 2019 - repositorio.ipl.pt
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
BR da Cunha, LP Fonseca, CRC Calado - Antibiotics, 2019 - search.proquest.com
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
R da Cunha, C Fonseca - Antibiotics, 2019 - cir.nii.ac.jp
抄録< jats: p> Given the increase in antibiotic-resistant bacteria, alongside the alarmingly
low rate of newly approved antibiotics for clinical usage, we are on the verge of not having …
low rate of newly approved antibiotics for clinical usage, we are on the verge of not having …
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
B Ribeiro da Cunha, LP Fonseca… - Antibiotics (Basel …, 2019 - europepmc.org
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
[PDF][PDF] Antibiotic Discovery: Where Have We Come from, Where Do We Go?
BR da Cunha, LP Fonseca, CRC Calado - core.ac.uk
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
B Ribeiro da Cunha, LP Fonseca… - Antibiotics (2079 …, 2019 - search.ebscohost.com
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
[PDF][PDF] Antibiotic Discovery: Where Have We Come from, Where Do We Go?
BR da Cunha, LP Fonseca, CRC Calado - pdfs.semanticscholar.org
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
[HTML][HTML] Antibiotic Discovery: Where Have We Come from, Where Do We Go?
BR da Cunha, LP Fonseca, CRC Calado - Antibiotics, 2019 - ncbi.nlm.nih.gov
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
[PDF][PDF] Antibiotic Discovery: Where Have We Come from, Where Do We Go?
BR da Cunha, LP Fonseca, CRC Calado - academia.edu
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …